Global Novel Coronavirus (COVID-19) Vaccine Market Size, Status and Forecast 2020-2026

Global Novel Coronavirus (COVID-19) Vaccine Market Size, Status and Forecast 2020-2026

Apr 2020 QYResearch ICT130 Pages Price :
$ 3900
This report focuses on the global Novel Coronavirus (COVID-19) Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Coronavirus (COVID-19) Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise

Market segment by Type, the product can be split into
DNA
RNA
Others
Market segment by Application, split into
Mild Symptom Patient
Critically Ill Patient

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Novel Coronavirus (COVID-19) Vaccine status, future forecast, growth opportunity, key market and key players.
To present the Novel Coronavirus (COVID-19) Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Novel Coronavirus (COVID-19) Vaccine are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Novel Coronavirus (COVID-19) Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA
1.4.3 RNA
1.4.4 Others
1.5 Market by Application
1.5.1 Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application: 2020 VS 2026
1.5.2 Mild Symptom Patient
1.5.3 Critically Ill Patient
1.6 Coronavirus Disease 2019 (Covid-19): Novel Coronavirus (COVID-19) Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Novel Coronavirus (COVID-19) Vaccine Industry
1.6.1.1 Novel Coronavirus (COVID-19) Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Novel Coronavirus (COVID-19) Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Novel Coronavirus (COVID-19) Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Novel Coronavirus (COVID-19) Vaccine Market Perspective (2015-2026)
2.2 Novel Coronavirus (COVID-19) Vaccine Growth Trends by Regions
2.2.1 Novel Coronavirus (COVID-19) Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Novel Coronavirus (COVID-19) Vaccine Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
3.1 Novel Coronavirus (COVID-19) Vaccine Revenue by Players (2019-2020)
3.2 Novel Coronavirus (COVID-19) Vaccine Key Players Head office and Area Served
3.3 Key Players Novel Coronavirus (COVID-19) Vaccine Product/Solution/Service
3.4 Date of Enter into Novel Coronavirus (COVID-19) Vaccine Market
3.5 Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment Analysis
3.6 Global Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026)

5 Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026)

6 North America
6.1 North America Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
6.2 Novel Coronavirus (COVID-19) Vaccine Key Players in North America (2019-2020)
6.3 North America Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
6.4 North America Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

7 Europe
7.1 Europe Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
7.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Europe (2019-2020)
7.3 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
7.4 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

8 China
8.1 China Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
8.2 Novel Coronavirus (COVID-19) Vaccine Key Players in China (2019-2020)
8.3 China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
8.4 China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

9 Japan
9.1 Japan Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
9.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Japan (2019-2020)
9.3 Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
9.4 Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
10.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

11 India
11.1 India Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
11.2 Novel Coronavirus (COVID-19) Vaccine Key Players in India (2019-2020)
11.3 India Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
11.4 India Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Novel Coronavirus (COVID-19) Vaccine Market Forecast (2019-2026)
12.2 Novel Coronavirus (COVID-19) Vaccine Key Players in Central & South America (2019-2020)
12.3 Central & South America Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2015-2020)
12.4 Central & South America Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Inovio Pharmaceuticals
13.1.1 Inovio Pharmaceuticals Company Details
13.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Introduction
13.1.4 Inovio Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.1.5 Inovio Pharmaceuticals Recent Development
13.2 Takis Biotech (Evvivax)
13.2.1 Takis Biotech (Evvivax) Company Details
13.2.2 Takis Biotech (Evvivax) Business Overview and Its Total Revenue
13.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Introduction
13.2.4 Takis Biotech (Evvivax) Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.2.5 Takis Biotech (Evvivax) Recent Development
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Details
13.3.2 Zydus Cadila Business Overview and Its Total Revenue
13.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Introduction
13.3.4 Zydus Cadila Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.3.5 Zydus Cadila Recent Development
13.4 Codagenix, Inc.
13.4.1 Codagenix, Inc. Company Details
13.4.2 Codagenix, Inc. Business Overview and Its Total Revenue
13.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
13.4.4 Codagenix, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.4.5 Codagenix, Inc. Recent Development
13.5 GeoVax, Inc.
13.5.1 GeoVax, Inc. Company Details
13.5.2 GeoVax, Inc. Business Overview and Its Total Revenue
13.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
13.5.4 GeoVax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.5.5 GeoVax, Inc. Recent Development
13.6 Bravovax
13.6.1 Bravovax Company Details
13.6.2 Bravovax Business Overview and Its Total Revenue
13.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Introduction
13.6.4 Bravovax Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.6.5 Bravovax Recent Development
13.7 Janssen Pharmaceutical Companies
13.7.1 Janssen Pharmaceutical Companies Company Details
13.7.2 Janssen Pharmaceutical Companies Business Overview and Its Total Revenue
13.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Introduction
13.7.4 Janssen Pharmaceutical Companies Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.7.5 Janssen Pharmaceutical Companies Recent Development
13.8 Altimmune
13.8.1 Altimmune Company Details
13.8.2 Altimmune Business Overview and Its Total Revenue
13.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Introduction
13.8.4 Altimmune Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.8.5 Altimmune Recent Development
13.9 Vaxart
13.9.1 Vaxart Company Details
13.9.2 Vaxart Business Overview and Its Total Revenue
13.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Introduction
13.9.4 Vaxart Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.9.5 Vaxart Recent Development
13.10 CanSino Biologics
13.10.1 CanSino Biologics Company Details
13.10.2 CanSino Biologics Business Overview and Its Total Revenue
13.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Introduction
13.10.4 CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
13.10.5 CanSino Biologics Recent Development
13.11 ExpreS2ion Biotechnologies ApS
10.11.1 ExpreS2ion Biotechnologies ApS Company Details
10.11.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
10.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Introduction
10.11.4 ExpreS2ion Biotechnologies ApS Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.11.5 ExpreS2ion Biotechnologies ApS Recent Development
13.12 Clover Biopharmaceuticals
10.12.1 Clover Biopharmaceuticals Company Details
10.12.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
10.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Introduction
10.12.4 Clover Biopharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.12.5 Clover Biopharmaceuticals Recent Development
13.13 GSK
10.13.1 GSK Company Details
10.13.2 GSK Business Overview and Its Total Revenue
10.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Introduction
10.13.4 GSK Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.13.5 GSK Recent Development
13.14 Vaxil Bio Ltd.
10.14.1 Vaxil Bio Ltd. Company Details
10.14.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
10.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Introduction
10.14.4 Vaxil Bio Ltd. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.14.5 Vaxil Bio Ltd. Recent Development
13.15 Generex
10.15.1 Generex Company Details
10.15.2 Generex Business Overview and Its Total Revenue
10.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Introduction
10.15.4 Generex Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.15.5 Generex Recent Development
13.16 Novavax, Inc.
10.16.1 Novavax, Inc. Company Details
10.16.2 Novavax, Inc. Business Overview and Its Total Revenue
10.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
10.16.4 Novavax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.16.5 Novavax, Inc. Recent Development
13.17 Sanofi Pasteur
10.17.1 Sanofi Pasteur Company Details
10.17.2 Sanofi Pasteur Business Overview and Its Total Revenue
10.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Introduction
10.17.4 Sanofi Pasteur Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.17.5 Sanofi Pasteur Recent Development
13.18 Baylor
10.18.1 Baylor Company Details
10.18.2 Baylor Business Overview and Its Total Revenue
10.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Introduction
10.18.4 Baylor Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.18.5 Baylor Recent Development
13.19 iBio, Inc.
10.19.1 iBio, Inc. Company Details
10.19.2 iBio, Inc. Business Overview and Its Total Revenue
10.19.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
10.19.4 iBio, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.19.5 iBio, Inc. Recent Development
13.20 Moderna, Inc.
10.20.1 Moderna, Inc. Company Details
10.20.2 Moderna, Inc. Business Overview and Its Total Revenue
10.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Introduction
10.20.4 Moderna, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.20.5 Moderna, Inc. Recent Development
13.21 Curevac
10.21.1 Curevac Company Details
10.21.2 Curevac Business Overview and Its Total Revenue
10.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Introduction
10.21.4 Curevac Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.21.5 Curevac Recent Development
13.22 ImmunoPrecise
10.22.1 ImmunoPrecise Company Details
10.22.2 ImmunoPrecise Business Overview and Its Total Revenue
10.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Introduction
10.22.4 ImmunoPrecise Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2020))
10.22.5 ImmunoPrecise Recent Development

14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porters Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables
Table 1. Novel Coronavirus (COVID-19) Vaccine Key Market Segments
Table 2. Key Players Covered: Ranking by Novel Coronavirus (COVID-19) Vaccine Revenue
Table 3. Ranking of Global Top Novel Coronavirus (COVID-19) Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DNA
Table 6. Key Players of RNA
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Novel Coronavirus (COVID-19) Vaccine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Novel Coronavirus (COVID-19) Vaccine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Novel Coronavirus (COVID-19) Vaccine Players to Combat Covid-19 Impact
Table 13. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Regions 2019-2026
Table 17. Market Top Trends
Table 18. Market Use Cases
Table 19. Global Novel Coronavirus (COVID-19) Vaccine Revenue by Players (2019-2020) (Million US$)
Table 20. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players (2019-2020)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Novel Coronavirus (COVID-19) Vaccine Product Solution and Service
Table 23. Date of Enter into Novel Coronavirus (COVID-19) Vaccine Market
Table 24. Global Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment Analysis (Million USD)
Table 25. Global Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization (Million USD)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 28. Global Novel Coronavirus (COVID-19) Vaccine Market Size Share by Type (2019-2026)
Table 29. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 30. Global Novel Coronavirus (COVID-19) Vaccine Market Size Share by Application (2019-2026)
Table 31. North America Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 32. North America Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 33. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 34. North America Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 35. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 36. North America Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 37. Europe Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 38. Europe Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 39. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 40. Europe Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 41. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 42. Europe Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 43. China Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 44. China Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 45. China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 46. China Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 47. China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 48. China Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 49. Japan Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 50. Japan Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 51. Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 52. Japan Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 53. Japan Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 54. Japan Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 55. Southeast Asia Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 56. Southeast Asia Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 57. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 58. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 59. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 60. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 61. India Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 62. India Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 63. India Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 64. India Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 65. India Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 66. India Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 67. Central & South America Key Players Novel Coronavirus (COVID-19) Vaccine Revenue (2019-2020) (Million US$)
Table 68. Central & South America Key Players Novel Coronavirus (COVID-19) Vaccine Market Share (2019-2020)
Table 69. Central & South America Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2026) (Million US$)
Table 70. Central & South America Novel Coronavirus (COVID-19) Vaccine Market Share by Type (2019-2026)
Table 71. Central & South America Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2026) (Million US$)
Table 72. Central & South America Novel Coronavirus (COVID-19) Vaccine Market Share by Application (2019-2026)
Table 73. Inovio Pharmaceuticals Company Details
Table 74. Inovio Pharmaceuticals Business Overview
Table 75. Inovio Pharmaceuticals Product
Table 76. Company Description and Business Overview
Table 77. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 78. Inovio Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 79. Inovio Pharmaceuticals Recent Development
Table 80. Takis Biotech (Evvivax) Company Details
Table 81. Takis Biotech (Evvivax) Business Overview
Table 82. Takis Biotech (Evvivax) Product
Table 83. Company Description and Business Overview
Table 84. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product
Table 85. Takis Biotech (Evvivax) Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 86. Takis Biotech (Evvivax) Recent Development
Table 87. Zydus Cadila Company Details
Table 88. Zydus Cadila Business Overview
Table 89. Zydus Cadila Product
Table 90. Company Description and Business Overview
Table 91. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product
Table 92. Zydus Cadila Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 93. Zydus Cadila Recent Development
Table 94. Codagenix, Inc. Company Details
Table 95. Codagenix, Inc. Business Overview
Table 96. Codagenix, Inc. Product
Table 97. Company Description and Business Overview
Table 98. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 99. Codagenix, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 100. Codagenix, Inc. Recent Development
Table 101. GeoVax, Inc. Company Details
Table 102. GeoVax, Inc. Business Overview
Table 103. GeoVax, Inc. Product
Table 104. Company Description and Business Overview
Table 105. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 106. GeoVax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 107. GeoVax, Inc. Recent Development
Table 108. Bravovax Company Details
Table 109. Bravovax Business Overview
Table 110. Bravovax Product
Table 111. Company Description and Business Overview
Table 112. Bravovax Novel Coronavirus (COVID-19) Vaccine Product
Table 113. Bravovax Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 114. Bravovax Recent Development
Table 115. Janssen Pharmaceutical Companies Company Details
Table 116. Janssen Pharmaceutical Companies Business Overview
Table 117. Janssen Pharmaceutical Companies Product
Table 118. Company Description and Business Overview
Table 119. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product
Table 120. Janssen Pharmaceutical Companies Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 121. Janssen Pharmaceutical Companies Recent Development
Table 122. Altimmune Business Overview
Table 123. Altimmune Product
Table 124. Altimmune Company Details
Table 125. Company Description and Business Overview
Table 126. Altimmune Novel Coronavirus (COVID-19) Vaccine Product
Table 127. Altimmune Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 128. Altimmune Recent Development
Table 129. Vaxart Company Details
Table 130. Vaxart Business Overview
Table 131. Vaxart Product
Table 132. Company Description and Business Overview
Table 133. Vaxart Novel Coronavirus (COVID-19) Vaccine Product
Table 134. Vaxart Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 135. Vaxart Recent Development
Table 136. CanSino Biologics Company Details
Table 137. CanSino Biologics Business Overview
Table 138. CanSino Biologics Product
Table 139. Company Description and Business Overview
Table 140. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product
Table 141. CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 142. CanSino Biologics Recent Development
Table 143. ExpreS2ion Biotechnologies ApS Company Details
Table 144. ExpreS2ion Biotechnologies ApS Business Overview
Table 145. ExpreS2ion Biotechnologies ApS Product
Table 146. Company Description and Business Overview
Table 147. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product
Table 148. ExpreS2ion Biotechnologies ApS Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 149. ExpreS2ion Biotechnologies ApS Recent Development
Table 150. Clover Biopharmaceuticals Company Details
Table 151. Clover Biopharmaceuticals Business Overview
Table 152. Clover Biopharmaceuticals Product
Table 153. Company Description and Business Overview
Table 154. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 155. Clover Biopharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 156. Clover Biopharmaceuticals Recent Development
Table 157. GSK Company Details
Table 158. GSK Business Overview
Table 159. GSK Product
Table 160. Company Description and Business Overview
Table 161. GSK Novel Coronavirus (COVID-19) Vaccine Product
Table 162. GSK Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 163. GSK Recent Development
Table 164. Vaxil Bio Ltd. Company Details
Table 165. Vaxil Bio Ltd. Business Overview
Table 166. Vaxil Bio Ltd. Product
Table 167. Company Description and Business Overview
Table 168. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product
Table 169. Vaxil Bio Ltd. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 170. Vaxil Bio Ltd. Recent Development
Table 171. Generex Company Details
Table 172. Generex Business Overview
Table 173. Generex Product
Table 174. Company Description and Business Overview
Table 175. Generex Novel Coronavirus (COVID-19) Vaccine Product
Table 176. Generex Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 177. Generex Recent Development
Table 178. Novavax, Inc. Company Details
Table 179. Novavax, Inc. Business Overview
Table 180. Novavax, Inc. Product
Table 181. Company Description and Business Overview
Table 182. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 183. Novavax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 184. Novavax, Inc. Recent Development
Table 185. Sanofi Pasteur Company Details
Table 186. Sanofi Pasteur Business Overview
Table 187. Sanofi Pasteur Product
Table 188. Company Description and Business Overview
Table 189. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product
Table 190. Sanofi Pasteur Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 191. Sanofi Pasteur Recent Development
Table 192. Baylor Company Details
Table 193. Baylor Business Overview
Table 194. Baylor Product
Table 195. Company Description and Business Overview
Table 196. Baylor Novel Coronavirus (COVID-19) Vaccine Product
Table 197. Baylor Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 198. Baylor Recent Development
Table 199. iBio, Inc. Company Details
Table 200. iBio, Inc. Business Overview
Table 201. iBio, Inc. Product
Table 202. Company Description and Business Overview
Table 203. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 204. iBio, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 205. iBio, Inc. Recent Development
Table 206. Moderna, Inc. Company Details
Table 207. Moderna, Inc. Business Overview
Table 208. Moderna, Inc. Product
Table 209. Company Description and Business Overview
Table 210. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 211. Moderna, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 212. Moderna, Inc. Recent Development
Table 213. Curevac Company Details
Table 214. Curevac Business Overview
Table 215. Curevac Product
Table 216. Company Description and Business Overview
Table 217. Curevac Novel Coronavirus (COVID-19) Vaccine Product
Table 218. Curevac Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 219. Curevac Recent Development
Table 220. ImmunoPrecise Company Details
Table 221. ImmunoPrecise Business Overview
Table 222. ImmunoPrecise Product
Table 223. Company Description and Business Overview
Table 224. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product
Table 225. ImmunoPrecise Revenue in Novel Coronavirus (COVID-19) Vaccine Business 2019 and 2020 (Million US$)
Table 226. ImmunoPrecise Recent Development
Table 227. Company Description and Business Overview
Table 228. Company Description and Business Overview
Table 229. Company Description and Business Overview
Table 230. Company Description and Business Overview
Table 231. Company Description and Business Overview
Table 232. Company Description and Business Overview
Table 233. Company Description and Business Overview
Table 234. Company Description and Business Overview
Table 235. Company Description and Business Overview
Table 236. Company Description and Business Overview
Table 237. Company Description and Business Overview
Table 238. Company Description and Business Overview
Table 239. Company Description and Business Overview
Table 240. Company Description and Business Overview
Table 241. Company Description and Business Overview
Table 242. Company Description and Business Overview
Table 243. Company Description and Business Overview
Table 244. Company Description and Business Overview
Table 245. Key Drivers: Impact Analysis (2021-2026)
Table 246. Key Opportunities
Table 247. Key Challenges
Table 248. Research Programs/Design for This Report
Table 249. Key Data Information from Secondary Sources
Table 250. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Type: 2020 VS 2026
Figure 2. DNA Features
Figure 3. RNA Features
Figure 4. Others Features
Figure 5. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application: 2020 VS 2026
Figure 6. Mild Symptom Patient Case Studies
Figure 7. Critically Ill Patient Case Studies
Figure 8. Novel Coronavirus (COVID-19) Vaccine Report Years Considered
Figure 9. Global Novel Coronavirus (COVID-19) Vaccine and Growth Rate (2019-2026) (Million US$)
Figure 10. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Regions (2019-2026)
Figure 11. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players in 2019
Figure 12. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2019-2026)
Figure 13. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2019-2026)
Figure 14. North America Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 15. Europe Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. China Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. Japan Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. India Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Central & South America Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top